InBio Reports Derivative Trading Losses Amounting to 8.2 Billion KRW
[Asia Economy Reporter Park Jihwan] InBio announced on the 26th that it incurred a loss of 8.2 billion KRW from derivative transactions.
Hot Picks Today
"Parents Deposited 10 Million Won for Me"... Se...
- "No Garbage Bags Available": Japan Faces Shortages, Suspends Mandatory Use Amid ...
- "SK Hynix Stock Windfall"... Teenager With Wads of Cash Turns Thief at Jewelry S...
- "Major Crash Is Coming... Buy Even If You Have to Skip a Meal" 'Rich Dad' Shares...
- "Save 30 Million Won, Grow It to 100 Million": Dramatic Pledge Sparks "Is This a...
The company stated, "A derivative valuation loss was recognized due to the difference between the issuance price of the new stock subscription rights and the stock price caused by the stock price increase," adding, "This loss corresponds to a valuation loss based on fair value assessment and does not involve any cash outflow."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
